Alexandre R. Zlotta

17.0k total citations · 2 hit papers
327 papers, 11.0k citations indexed

About

Alexandre R. Zlotta is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Alexandre R. Zlotta has authored 327 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Pulmonary and Respiratory Medicine, 147 papers in Surgery and 62 papers in Urology. Recurrent topics in Alexandre R. Zlotta's work include Prostate Cancer Diagnosis and Treatment (140 papers), Bladder and Urothelial Cancer Treatments (133 papers) and Prostate Cancer Treatment and Research (128 papers). Alexandre R. Zlotta is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (140 papers), Bladder and Urothelial Cancer Treatments (133 papers) and Prostate Cancer Treatment and Research (128 papers). Alexandre R. Zlotta collaborates with scholars based in Canada, Belgium and United States. Alexandre R. Zlotta's co-authors include Claude C. Schulman, Neil Fleshner, Bob Djavan, Michael Marberger, Antonio Finelli, Theodorus van der Kwast, Mesut Remzi, Michael A.S. Jewett, Yair Lotan and Shahrokh F. Shariat and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Alexandre R. Zlotta

317 papers receiving 10.6k citations

Hit Papers

Recurrence and Progression of Disease in Non–Muscle-Invas... 2009 2026 2014 2020 2009 2015 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
    2009 559 citations Bas W.G. van Rhijn, Maximilian Burger et al. European Urology profile →
  2. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
    2015 467 citations Alexandre R. Zlotta et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre R. Zlotta Canada 57 5.4k 5.1k 2.2k 2.2k 1.7k 327 11.0k
David P. Wood United States 62 7.9k 1.5× 6.2k 1.2× 2.5k 1.1× 2.1k 1.0× 1.9k 1.1× 281 14.8k
Patrick J. Bastian Germany 58 4.6k 0.9× 4.7k 0.9× 2.3k 1.0× 2.8k 1.3× 1.3k 0.7× 188 10.4k
Felix K.‐H. Chun Germany 55 8.0k 1.5× 3.7k 0.7× 1.4k 0.6× 1.7k 0.8× 2.2k 1.3× 600 11.8k
Dominique Chopin France 59 5.4k 1.0× 5.0k 1.0× 1.6k 0.7× 4.7k 2.1× 1.2k 0.7× 257 11.6k
Joseph L. Chin Canada 51 6.9k 1.3× 2.9k 0.6× 1.0k 0.5× 1.5k 0.7× 1.4k 0.8× 340 11.1k
Armen Aprikian Canada 48 4.2k 0.8× 3.0k 0.6× 946 0.4× 2.2k 1.0× 930 0.5× 279 8.7k
Ganesh V. Raj United States 53 5.8k 1.1× 3.2k 0.6× 1.5k 0.7× 4.0k 1.9× 682 0.4× 195 11.5k
Jason A. Efstathiou United States 49 5.0k 0.9× 4.9k 1.0× 1.7k 0.8× 1.9k 0.9× 470 0.3× 314 11.4k
Mitchell C. Benson United States 52 8.6k 1.6× 3.1k 0.6× 1.2k 0.6× 3.9k 1.8× 1.4k 0.8× 268 13.3k
E. David Crawford United States 38 5.1k 1.0× 3.5k 0.7× 1.6k 0.7× 990 0.5× 843 0.5× 133 9.1k

Countries citing papers authored by Alexandre R. Zlotta

Since Specialization
Citations

This map shows the geographic impact of Alexandre R. Zlotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre R. Zlotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre R. Zlotta more than expected).

Fields of papers citing papers by Alexandre R. Zlotta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre R. Zlotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre R. Zlotta. The network helps show where Alexandre R. Zlotta may publish in the future.

Co-authorship network of co-authors of Alexandre R. Zlotta

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre R. Zlotta. A scholar is included among the top collaborators of Alexandre R. Zlotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre R. Zlotta. Alexandre R. Zlotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghai, Sangeet, Antonio Finelli, Katherine Lajkosz, et al.. (2024). MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial. Radiology. 310(3). e231473–e231473. 10 indexed citations
2.
Tan, Guan Hee, Dominik Deniffel, Antonio Finelli, et al.. (2023). Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance. Urologic Oncology Seminars and Original Investigations. 41(3). 146.e23–146.e28.
3.
Kulkarni, Girish S., Kyle A. Richards, Peter C. Black, et al.. (2023). MP63-01 AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS). The Journal of Urology. 209(Supplement 4). 3 indexed citations
4.
Roumiguié, M., et al.. (2023). Long-term Recurrence Rates of Low-risk Non–muscle-invasive Bladder Cancer—How Long Is Cystoscopic Surveillance Necessary?. European Urology Focus. 10(1). 189–196. 8 indexed citations
5.
Bernardino, Rui, Rashid K. Sayyid, Ricardo Leão, et al.. (2023). Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer. British Journal of Urology. 132(6). 638–640. 3 indexed citations
6.
Ghai, Sangeet, Nathan Perlis, Katherine Lajkosz, et al.. (2022). Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. Radiology. 305(2). 390–398. 22 indexed citations
7.
Bhindi, Bimal, Girish S. Kulkarni, D. Robert Siemens, et al.. (2021). Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version. Canadian Urological Association Journal. 15(8). 230–9. 9 indexed citations
8.
Putte, Elisabeth E. Fransen van de, Judith Bosschieter, Theodorus van der Kwast, et al.. (2018). The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer. British Journal of Urology. 122(6). 978–985. 23 indexed citations
9.
Sayyid, Rashid K., Dharmendra Dingar, Joshua M. Diamond, et al.. (2017). What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?. Canadian Urological Association Journal. 11(3-4). 118–118. 4 indexed citations
10.
Sayyid, Rashid K., Andrew Evans, Karen Hersey, et al.. (2016). A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy. Clinical Cancer Research. 23(8). 1974–1980. 34 indexed citations
11.
Boström, Peter J., Tuomas Mirtti, Bas van Rhijn, et al.. (2016). Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer. 2(2). 263–272. 6 indexed citations
12.
Bhindi, Bimal, David Margel, Greg Trottier, et al.. (2013). Obesity Is Associated With Larger Prostate Volume but not With Worse Urinary Symptoms: Analysis of a Large Multiethnic Cohort. Urology. 83(1). 81–87. 22 indexed citations
13.
Protzel, Chris, Antonio Alcaraz, Simon Horenblas, et al.. (2009). Lymphadenectomy in the Surgical Management of Penile Cancer. European Urology. 55(5). 1075–1088. 164 indexed citations
14.
Lemy, Anne, Karl Martin Wissing, Sandrine Rorive, et al.. (2008). Late Onset of Bladder Urothelial Carcinoma After Kidney Transplantation for End-Stage Aristolochic Acid Nephropathy: A Case Series With 15-Year Follow-up. American Journal of Kidney Diseases. 51(3). 471–477. 80 indexed citations
15.
Djavan, Bob, V. Ravery, Bernardo Rocco, et al.. (2007). European Study of Radical Prostatectomy: time trends in Europe, 1993–2005. British Journal of Urology. 100(s2). 22–25. 14 indexed citations
16.
Zlotta, Alexandre R., Jean‐Paul Van Vooren, Olivier Denis, et al.. (2000). What are the immunologically active components of Bacille Calmette-Guérin in therapy of superficial bladder cancer?. International Journal of Cancer. 87(6). 844–852. 55 indexed citations
17.
Anaf, Vincent, Christophe Vaessen, Alexandre R. Zlotta, et al.. (1999). Laparoscopic partial bladder resection for bladder endometriosis. Gynaecological Endoscopy. 8(1). 11–15. 2 indexed citations
18.
Schulman, Claude C., Wim P.J. Witjes, Alexandre R. Zlotta, & F.M.J. Debruyne. (1997). Neoadjuvant combined androgen deprivation therapy in locally confined prostate carcinoma: short term results of a European randomized study. Radboud Repository (Radboud University). 80. 211–216. 2 indexed citations
19.
Raviv, Gil, et al.. (1996). Néoplasie intraépithéliale prostatique de haut grade: detection et association avec le cancer de la prostate.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 64(1). 11–15. 1 indexed citations
20.
Velthoven, Roland van, Michel Pétein, Alexandre R. Zlotta, et al.. (1995). Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. Human Pathology. 26(1). 3–11. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David P. Wood Breakdown of academic impact, for papers by Patrick J. Bastian Breakdown of academic impact, for papers by Felix K.‐H. Chun Breakdown of academic impact, for papers by Dominique Chopin Breakdown of academic impact, for papers by Joseph L. Chin Breakdown of academic impact, for papers by Armen Aprikian Breakdown of academic impact, for papers by Ganesh V. Raj Breakdown of academic impact, for papers by Jason A. Efstathiou Breakdown of academic impact, for papers by Mitchell C. Benson Breakdown of academic impact, for papers by E. David Crawford
Rankless by CCL
2026